Pharmaceutical Online - Agatha Wisniowska and Ashwin Singhania, Guidehouse
For pharmaceutical companies seeking their next major opportunity, multiple recent breakthroughs in novel mechanisms of action (MOAs) have set the stage for advances in immunology treatment options. However, analysis identifies one market in particular — nephrology — among the best therapeutic development bets, due to current market conditions and a significant unmet need.